Case number 3:24-cv-05887
ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 12, 2024 | 15 | PRETRIAL CONSOLIDATION ORDER Directing that all papers be filed and maintained in Civil Action No. 23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/12/2024. (amv) (Entered: 08/13/2024) (7) |
| Aug 12, 2024 | 16 | STIPULATION AND CONSOLIDATED AMENDED PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/12/2024. (amv) (Entered: 08/13/2024) (8) |
| Aug 7, 2024 | N/A | Text Minute Entry for proceedings held before Magistrate Judge Tonianne J. Bongiovanni: Telephone Conference held on 8/7/2024. An update regarding status of discovery will be submitted by 12/11/2024. The cross use of Defendants' confidential information will be addressed when the parties advise that a resolution is necessary. (jem) (Entered: 08/09/2024) (0) |
| Jul 25, 2024 | 14 | TEXT ORDER: Oral Argument as to the dispute regarding the Discovery Confidentiality Order set for 8/7/2024 at 12:00 PM via via MS TEAMS before Magistrate Judge Tonianne J. Bongiovanni. The Court shall circulate the MS TEAMS link for the conference on a later date. So Ordered by Magistrate Judge Tonianne J. Bongiovanni on 7/25/2024. (jem) (Entered: 07/25/2024) (0) |
| Jun 5, 2024 | N/A | CLERK'S QUALITY CONTROL MESSAGE - Case Closed in Error, Please Disregard. (amv) (Entered: 06/05/2024) (0) |
| Jun 5, 2024 | 13 | Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/05/2024) (2) |
| May 30, 2024 | 12 | ORDER Consolidating Civil Action Nos. 3:23-796, 3:24-641, 3:24-5887, and 3:24-5889 under Civil Action No. 3:23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 5/30/2024. (amv) (Entered: 05/31/2024) (4) |
| May 10, 2024 | 9 | WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. NATCO PHARMA LIMITED waiver sent on 5/7/2024, answer due 7/8/2024. (CHEVALIER, CHARLES) (Entered: 05/10/2024) (1) |
| May 10, 2024 | 10 | WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. NATCO PHARMA INC. waiver sent on 5/7/2024, answer due 7/8/2024. (CHEVALIER, CHARLES) (Entered: 05/10/2024) (1) |
| May 10, 2024 | 11 | NOTICE of Appearance by JAMES S. RICHTER on behalf of NATCO PHARMA INC., NATCO PHARMA LIMITED (RICHTER, JAMES) (Entered: 05/10/2024) (1) |
| May 8, 2024 | 7 | AO120 Patent/Trademark Form filed. (kht) (Entered: 05/08/2024) (1) |
| May 8, 2024 | 8 | SUMMONS ISSUED as to NATCO PHARMA INC., NATCO PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 05/08/2024) (2) |
| May 7, 2024 | 1 | COMPLAINT against NATCO PHARMA INC., NATCO PHARMA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15347610) , Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('530 patent), # 2 Exhibit B ('001 patent), # 3 Certification Local Rule 11.2, # 4 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 05/07/2024) (0) |
| May 7, 2024 | 2 | Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 05/07/2024) (2) |
| May 7, 2024 | 3 | Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 05/07/2024) (2) |
| May 7, 2024 | 4 | Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 05/07/2024) (2) |
| May 7, 2024 | 5 | Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 05/07/2024) (2) |
| May 7, 2024 | 6 | Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck Sharp & Dohme LLC. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 05/07/2024) (2) |
| May 7, 2024 | N/A | Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (kht) (Entered: 05/08/2024) (0) |
